4,283 Shares in SPDR S&P Biotech ETF $XBI Acquired by Wealth Management Partners LLC

Wealth Management Partners LLC acquired a new stake in SPDR S&P Biotech ETF (NYSEARCA:XBIFree Report) in the 1st quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor acquired 4,283 shares of the exchange traded fund’s stock, valued at approximately $547,000.

Other hedge funds have also recently added to or reduced their stakes in the company. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC acquired a new position in shares of SPDR S&P Biotech ETF during the fourth quarter worth $27,000. Intesa Sanpaolo Wealth Management acquired a new stake in shares of SPDR S&P Biotech ETF during the 4th quarter valued at $30,000. SHP Wealth Management acquired a new stake in shares of SPDR S&P Biotech ETF during the 4th quarter valued at $31,000. Legacy Wealth Managment LLC ID acquired a new stake in shares of SPDR S&P Biotech ETF during the 4th quarter valued at $32,000. Finally, Smartleaf Asset Management LLC bought a new stake in SPDR S&P Biotech ETF during the 4th quarter worth $32,000.

SPDR S&P Biotech ETF Stock Up 0.8%

Shares of XBI opened at $147.03 on Wednesday. SPDR S&P Biotech ETF has a 12-month low of $82.04 and a 12-month high of $148.76. The business has a 50-day simple moving average of $134.19 and a two-hundred day simple moving average of $128.13. The stock has a market cap of $9.38 billion, a PE ratio of 11.47 and a beta of 0.85.

About SPDR S&P Biotech ETF

(Free Report)

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.

Further Reading

Want to see what other hedge funds are holding XBI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for SPDR S&P Biotech ETF (NYSEARCA:XBIFree Report).

Institutional Ownership by Quarter for SPDR S&P Biotech ETF (NYSEARCA:XBI)

Receive News & Ratings for SPDR S&P Biotech ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SPDR S&P Biotech ETF and related companies with MarketBeat.com's FREE daily email newsletter.